Generic placeholder image

Current Signal Transduction Therapy

Editor-in-Chief

ISSN (Print): 1574-3624
ISSN (Online): 2212-389X

Editorial

The Connections between Atrial Fibrillation and Mental Disorders: Role of Ca2+/cAMP Signalling

Author(s): Leandro Bueno Bergantin*

Volume 19, Issue 3, 2024

Published on: 24 May, 2024

Article ID: e240524230328 Pages: 3

DOI: 10.2174/0115743624316217240520113601

Open Access Journals Promotions 2
conference banner
[1]
Chung FP, Lin YJ. The connection between cardiac and mental disorder: Atrial fibrillation in patients with psychiatric disorder. Zhonghua Minguo Xinzangxue Hui Zazhi 2014; 30(1): 53-5.
[PMID: 27122768]
[2]
Bae NY, Lee SR, Choi EK, et al. Impact of mental disorders on the risk of atrial fibrillation in patients with diabetes mellitus: A nationwide population-based study. Cardiovasc Diabetol 2022; 21(1): 251.
[http://dx.doi.org/10.1186/s12933-022-01682-7] [PMID: 36397079]
[3]
Yang HY, Huang JH, Lin YK, Hsu CY, Chen SA, Chen YJ. Bipolar disorder and schizophrenia present different risks of atrial fibrillation: A nationwide population-based analysis. Zhonghua Minguo Xinzangxue Hui Zazhi 2014; 30(1): 46-52.
[PMID: 27122767]
[4]
Magnani JW, Rienstra M, Lin H, et al. Atrial fibrillation. Circulation 2011; 124(18): 1982-93.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.111.039677] [PMID: 22042927]
[5]
Miyasaka Y, Barnes ME, Gersh BJ, et al. Changing trends of hospital utilization in patients after their first episode of atrial fibrillation. Am J Cardiol 2008; 102(5): 568-72.
[http://dx.doi.org/10.1016/j.amjcard.2008.04.025] [PMID: 18721513]
[6]
Fitzgerald PJ. Elevated norepinephrine may be an etiological factor in a wide range of diseases: Age-related macular degeneration, systemic lupus erythematosus, atrial fibrillation, metabolic syndrome. Med Hypotheses 2013; 80(5): 558-63.
[http://dx.doi.org/10.1016/j.mehy.2013.01.018] [PMID: 23410497]
[7]
Bergantin LB. Depression rises the risk of hypertension incidence: Discussing the link through the Ca2+/cAMP signalling. Curr Hypertens Rev 2020; 16(1): 73-8.
[http://dx.doi.org/10.2174/1573402115666190116095223] [PMID: 30648516]
[8]
Park HW, Shen MJ, Lin SF, Fishbein MC, Chen LS, Chen PS. Neural mechanisms of atrial fibrillation. Curr Opin Cardiol 2012; 27(1): 24-8.
[http://dx.doi.org/10.1097/HCO.0b013e32834dc4e8] [PMID: 22139702]
[9]
Bergantin LB. Diabetes and inflammatory diseases: An overview from the perspective of Ca2+/3′-5′-cyclic adenosine monophosphate signaling. World J Diabetes 2021; 12(6): 767-79.
[http://dx.doi.org/10.4239/wjd.v12.i6.767] [PMID: 34168726]
[10]
Bergantin LB. Hypertension, diabetes and neurodegenerative diseases: Is there a clinical link through the Ca2+/cAMP signalling interaction? Curr Hypertens Rev 2019; 15(1): 32-9.
[http://dx.doi.org/10.2174/1573402114666180817113242] [PMID: 30117399]
[11]
Caricati-Neto A, García AG, Bergantin LB. Pharmacological implications of the Ca2+/cAMP signaling interaction: From risk for antihypertensive therapy to potential beneficial for neurological and psychiatric disorders. Pharmacol Res Perspect 2015; 3(5): e00181.
[http://dx.doi.org/10.1002/prp2.181] [PMID: 26516591]
[12]
Bergantin LB. A timeline of Ca2+/cAMP signalling: From basic research to potential therapeutics for dementia. Curr Alzheimer Res 2022; 19(3): 179-87.
[http://dx.doi.org/10.2174/1567205019666220415125447] [PMID: 35430979]
[13]
Bergantin LB. The Interactions among hypertension, cancer, and COVID-19: Perspective with regard to Ca2+/cAMP Signalling. Curr Cancer Drug Targets 2022; 22(5): 351-60.
[http://dx.doi.org/10.2174/1568009622666220215143805] [PMID: 35168520]
[14]
Segan L, Prabhu S, Kalman JM, Kistler PM. Atrial fibrillation and stress: A 2-way street? JACC Clin Electrophysiol 2022; 8(8): 1051-9.
[http://dx.doi.org/10.1016/j.jacep.2021.12.008] [PMID: 35981797]
[15]
Patel D, Mc Conkey ND, Sohaney R, Mc Neil A, Jedrzejczyk A, Armaganijan L. A systematic review of depression and anxiety in patients with atrial fibrillation: The mind-heart link. Cardiovasc Psychiatry Neurol 2013; 2013: 1-11.
[http://dx.doi.org/10.1155/2013/159850] [PMID: 23710335]
[16]
Bergantin L. A link among schizophrenia, diabetes, and asthma: Role of Ca2+/cAMP signaling. Brain Circ 2020; 6(3): 145-51.
[http://dx.doi.org/10.4103/bc.bc_66_19] [PMID: 33210037]
[17]
Bergantin LB. The clinical link between depression and obesity: Role of Ca2+/cAMP signalling. Psychiatry Res 2020; 291: 113167.
[http://dx.doi.org/10.1016/j.psychres.2020.113167] [PMID: 32562933]
[18]
Bergantin L. Ca2+/cAMP ratio: An inflammatory index for diabetes, hypertension, and COVID-19. World J Diabetes 2023; 14(3): 343-6.
[http://dx.doi.org/10.4239/wjd.v14.i3.343] [PMID: 37035235]

© 2024 Bentham Science Publishers | Privacy Policy